Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin‐resistant rats

No abstract is available for this paper.

• Publication year

  2013

• Venue

  British Journal of Pharmacology

• Publication date

  2013-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bph.12176PMID 23488656PMCID PMC3696328
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury.

  2013cited by this paper
• T‐type calcium channel blockade improves survival and cardiovascular function in thalassemic mice

  2012cited by this paper
• Sitagliptin promotes macrophage‐to‐faeces reverse cholesterol transport through reduced intestinal cholesterol absorption in obese insulin resistant CETP‐apoB100 transgenic mice

  2012cited by this paper
• High free fatty acids level related with cardiac dysfunction in obese rats.

  2012influential reference
• PPARγ agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets.

  2012cited by this paper
• Cardioprotective effects of metformin and vildagliptin in adult rats with insulin resistance induced by a high-fat diet.

  2012cited by this paper
• Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood–retinal barrier in a type 2 diabetes animal model

  2012cited by this paper
• Effects of DPP-4 inhibition on cardiac metabolism and function in mice.

  2011cited by this paper
• Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes

  2011cited by this paper
• Mitochondrial dysfunction and insulin resistance from the outside in: extracellular matrix, the cytoskeleton, and mitochondria.

  2011influential reference
• Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure

  2011cited by this paper
• Granulocyte-colony stimulating factor attenuates mitochondrial dysfunction induced by oxidative stress in cardiac mitochondria.

  2011cited by this paper
• Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis.

  2011cited by this paper
• Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone.

  2011cited by this paper
• Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice.

  2011cited by this paper
• Sitagliptin lowers glucagon and improves glucose tolerance in prediabetic obese SHROB rats

  2010influential reference
• Guidelines for reporting experiments involving animals: the ARRIVE guidelines

  2010cited by this paper
• DPP-4 Inhibition by Sitagliptin Improves the Myocardial Response to Dobutamine Stress and Mitigates Stunning in a Pilot Study of Patients With Coronary Artery Disease

  2010cited by this paper
• Effects of curcuminoid supplement on cardiac autonomic status in high-fat-induced obese rats.

  2009cited by this paper
• Chronic Glucagon-Like Peptide-1 Infusion Sustains Left Ventricular Systolic Function and Prolongs Survival in the Spontaneously Hypertensive, Heart Failure–Prone Rat

  2008cited by this paper
• Muscle insulin resistance: A case of fat overconsumption, not mitochondrial dysfunction

  2008influential reference
• Phosphoethanolamine-complexed C-reactive protein: a pharmacological-like macromolecule that binds to native low-density lipoprotein in human serum.

  2008cited by this paper
• Incretin Receptors for Glucagon-Like Peptide 1 and Glucose-Dependent Insulinotropic Polypeptide Are Essential for the Sustained Metabolic Actions of Vildagliptin in Mice

  2007cited by this paper
• Heart rate variability in beta-thalassemic mice.

  2007cited by this paper
• The Role of Vildagliptin in the Management of Type 2 Diabetes Mellitus

  2007cited by this paper
• Metallothionein Prevents High-Fat Diet–Induced Cardiac Contractile Dysfunction

  2007cited by this paper
• Heart rate variability in -thalassemic mice

  2007cited by this paper
• Heart rate variability in myocardial infarction and heart failure.

  2007cited by this paper
• Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats

  2005cited by this paper
• Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury.

  2005cited by this paper
• Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes.

  2005cited by this paper
• Acute and Chronic Effects of the Incretin Enhancer Vildagliptin in Insulin-Resistant Rats

  2005influential reference
• Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes.

  2004cited by this paper
• A sensitive and specific polymerase chain reaction-based assay for the diagnosis of cytomegalovirus retinitis.

  1995influential reference
• 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(5):2078–2084 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-031907 Inhibition of Dipeptidyl Peptidase-4 Reduces Glycemia, Sustains Insulin Levels

  year unknowncited by this paper

• Myocardial ischemia reperfusion in diabetes: mechanism of injury and its drug treatment

  2026cites this paper
• Sitagliptin alleviates renal steatosis and endoplasmic reticulum stress in high fat diet-induced obese rats by targeting SREBP-1/CD36 signaling pathway.

  2024cites this paper
• Cyclosorus terminans extract mitigates submandibular gland changes associated with high-fat diet consumption in male rats.

  2024cites this paper
• Cyclosporine-induced kidney damage was halted by sitagliptin and hesperidin via increasing Nrf2 and suppressing TNF-α, NF-κB, and Bax

  2024cites this paper
• Mitochondrial quality control in cardiac fibrosis: Epigenetic mechanisms and therapeutic strategies.

  2023cites this paper
• Acetylcholine receptor agonists effectively attenuated multiple program cell death pathways and improved left ventricular function in trastuzumab-induced cardiotoxicity in rats.

  2023cites this paper
• Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways

  2023influential citation
• Roles of mitochondrial dynamics and mitophagy in diabetic myocardial microvascular injury

  2023cites this paper
• Targeting mitochondrial quality control for diabetic cardiomyopathy: Therapeutic potential of hypoglycemic drugs.

  2023cites this paper
• Vagus nerve stimulation and acetylcholinesterase inhibitor donepezil provide cardioprotection against trastuzumab-induced cardiotoxicity in rats by attenuating mitochondrial dysfunction.

  2023cites this paper
• A novel combination of sitagliptin and melatonin ameliorates T2D manifestations: studies on experimental diabetic models

  2023cites this paper
• An Overview of the Cardioprotective Effects of Novel Antidiabetic Classes: Focus on Inflammation, Oxidative Stress, and Fibrosis

  2023cites this paper
• GSDMD-mediated pyroptosis dominantly promotes left ventricular remodeling and dysfunction in post-myocardial infarction: a comparison across modes of programmed cell death and mitochondrial involvement

  2023cites this paper
• Combined Caloric Restriction and Exercise Provides Greater Metabolic and Neurocognitive Benefits than either as a Monotherapy in Obesity With or Without Estrogen Deprivation.

  2022cites this paper
• Melatonin and metformin ameliorated trastuzumab-induced cardiotoxicity through the modulation of mitochondrial function and dynamics without reducing its anticancer efficacy.

  2022cites this paper
• Extracellular Vesicles Released after Doxorubicin Treatment in Rats Protect Cardiomyocytes from Oxidative Damage and Induce Pro-Inflammatory Gene Expression in Macrophages

  2022cites this paper
• Ranolazine alleviated cardiac/brain dysfunction in doxorubicin-treated rats.

  2022cites this paper
• Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs

  2022cites this paper
• Therapeutic potential of a single-dose melatonin in the attenuation of cardiac ischemia/reperfusion injury in prediabetic obese rats

  2022cites this paper
• Promoting mitochondrial fusion in doxorubicin-induced cardiotoxicity: a novel therapeutic target for cardioprotection.

  2022cites this paper
• Sexual dimorphism in cardiometabolic and cardiac mitochondrial function in obese rats following sex hormone deprivation

  2022cites this paper
• MOSUL JOURNAL OF NURSING

  2022cites this paper
• Donepezil Protects Against Doxorubicin-Induced Chemobrain in Rats via Attenuation of Inflammation and Oxidative Stress Without Interfering With Doxorubicin Efficacy

  2021cites this paper
• The differences in mitochondrial function, mitochondrial dynamics, and cell death between odontogenic cysts/tumors and normal dental follicles.

  2021cites this paper
• Oxidative stress and hepatocellular mitochondrial dysfunction attenuated by asiatic acid in streptozotocin-induced diabetic rats

  2021cites this paper
• DPP4 Activity, Hyperinsulinemia and Atherosclerosis.

  2021cites this paper
• Vildagliptin Attenuates Myocardial Dysfunction and Restores Autophagy via miR-21/SPRY1/ERK in Diabetic Mice Heart

  2021cites this paper
• Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy.

  2021cites this paper
• Inhibition of myeloid differentiation factor 2 attenuates cardiometabolic impairments via reducing cardiac mitochondrial dysfunction, inflammation, apoptosis and ferroptosis in prediabetic rats.

  2021cites this paper
• Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis.

  2021cites this paper
• A molecular link between diabetes and breast cancer: Therapeutic potential of repurposing incretin-based therapies for breast cancer.

  2021cites this paper
• PCSK9 inhibitor effectively attenuates cardiometabolic impairment in obese-insulin resistant rats.

  2020cites this paper
• Obesity-Induced Heart Rate Variability Impairment and Decreased Systolic Function in Obese Male Dogs

  2020cites this paper
• Acute metformin treatment provides cardioprotection via improved mitochondrial function in cardiac ischemia / reperfusion injury.

  2020cites this paper
• Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy

  2020cites this paper
• The Effect of Dipeptidyl Peptidase-4 Inhibitors or Curcumin on Diet Induced Metabolic Syndrome with Cardiac Dysfunction in Rats

  2020cites this paper
• PCSK9 inhibitor and atorvastatin reduce cardiac impairment in ovariectomized prediabetic rats via improved mitochondrial function and Ca2+ regulation

  2020cites this paper
• Exercise with calorie restriction improves cardiac function via attenuating mitochondrial dysfunction in ovariectomized prediabetic rats.

  2020cites this paper
• N-acetylcysteine Restored Heart Rate Variability and Prevented Serious Adverse Events in Transfusion-dependent Thalassemia Patients: a Double-blind Single Center Randomized Controlled Trial

  2020cites this paper
• Vildagliptin protects hypoxia/reoxygenation-induced injury of cardiac microvascular endothelial cells.

  2020cites this paper
• Impaired renal organic anion transport 1 (SLC22A6) and its regulation following acute myocardial infarction and reperfusion injury in rats.

  2019cites this paper
• The effects of acetylcholinesterase inhibitors on the heart in acute myocardial infarction and heart failure: From cells to patient reports

  2019cites this paper
• Vildagliptin, a dipeptidyl peptidase-4 inhibitor, attenuated endothelial dysfunction through miRNAs in diabetic rats

  2019cites this paper
• Pretreatment with vildagliptin boosts ischemic-postconditioning effects on cardioprotection and expression profile of genes regulating autophagy and mitochondrial fission/fusion in diabetic heart with reperfusion injury

  2019cites this paper
• Ablation of TMEM126B protects against heart injury via improving mitochondrial function in high fat diet (HFD)-induced mice.

  2019cites this paper
• Vildagliptin reduces myocardial ischemia-induced arrhythmogenesis via modulating inflammatory responses and promoting expression of genes regulating mitochondrial biogenesis in rats with type-II diabetes

  2019cites this paper
• Impact of vildagliptin on vascular and fibrotic remodeling of myocardium in experimental diabetic cardiomyopathy.

  2019cites this paper
• Effect of DPP-4 inhibitor sitagliptin against ischemia-reperfusion (I/R) injury in hyperlipidemic animals

  2019influential citation
• Protective effect of dipeptidyl peptidase-4 inhibitors in testicular torsion/detorsion in rats: a possible role of HIF-1α and nitric oxide

  2019cites this paper
• Combination of exercise and calorie restriction exerts greater efficacy on cardioprotection than monotherapy in obese-insulin resistant rats through the improvement of cardiac calcium regulation.

  2019cites this paper
• Mitochondrial Dynamic Modulation Exerts Cardiometabolic Protection in Obese Insulin-Resistant Rats.

  2019cites this paper
• Combined low-dose testosterone and vildagliptin confers cardioprotection in castrated obese rats.

  2019cites this paper
• The effect of exenatide (a GLP‐1 analog) and sitagliptin (a DPP‐4 inhibitor) on plasma platelet‐activating factor acetylhydrolase (PAF‐AH) activity and concentration in normal and fructose‐fed rats

  2019cites this paper
• The Use of Hydrogen Sulfide Donor in Cardiac Control During Low Doses of Ionizing Radiation (Experimental Study)1

  2018cites this paper
• Increased sympathovagal imbalance evaluated by heart rate variability is associated with decreased T2* MRI and left ventricular function in transfusion-dependent thalassemia patients

  2018cites this paper
• Chronic treatment with prebiotics, probiotics and synbiotics attenuated cardiac dysfunction by improving cardiac mitochondrial dysfunction in male obese insulin-resistant rats

  2018cites this paper
• Testosterone Deprivation Aggravates Left-Ventricular Dysfunction in Male Obese Insulin-Resistant Rats via Impairing Cardiac Mitochondrial Function and Dynamics Proteins

  2018cites this paper
• Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, Improves Trabecular Bone Mineral Density and Microstructure in Obese, Insulin-Resistant, Pre-diabetic Rats.

  2018cites this paper
• Increased plasma FGF21 level as an early biomarker for insulin resistance and metabolic disturbance in obese insulin-resistant rats

  2018cites this paper
• Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin

  2018cites this paper
• Dipeptidyl peptidase-4 inhibitor enhances restoration of salivary glands impaired by obese-insulin resistance.

  2018cites this paper
• Mechanisms and pathways of anti‐inflammatory activity of DPP‐4 inhibitors in cardiovascular and renal protection

  2018cites this paper
• Estrogen deprivation aggravates cardiometabolic dysfunction in obese‐insulin resistant rats through the impairment of cardiac mitochondrial dynamics

  2018cites this paper
• Differential associations of lower cardiac vagal tone with insulin resistance and insulin secretion in recently diagnosed type 1 and type 2 diabetes.

  2018cites this paper
• A Possible Mechanism: Vildagliptin Prevents Aortic Dysfunction through Paraoxonase and Angiopoietin-Like 3

  2018cites this paper
• Combination of Vildagliptin and Ischemic Postconditioning in Diabetic Hearts as a Working Strategy to Reduce Myocardial Reperfusion Injury by Restoring Mitochondrial Function and Autophagic Activity

  2018cites this paper
• Improved glucose homeostasis in male obese Zucker rats coincides with enhanced baroreflexes and activation of the nucleus tractus solitarius.

  2018cites this paper
• High‐Saturated Fat High‐Sugar Diet Accelerates Left‐Ventricular Dysfunction Faster than High‐Saturated Fat Diet Alone via Increasing Oxidative Stress and Apoptosis in Obese‐Insulin Resistant Rats

  2018cites this paper
• Mitochondrial dysfunction in diabetes and the regulatory roles of antidiabetic agents on the mitochondrial function

  2018cites this paper
• A closer look at heart failure in patients with concurrent diabetes mellitus using glucose lowering drugs

  2018cites this paper
• Novel potentials of dipeptidyl peptidase-4 inhibitor sitagliptin against ischemia-reperfusion (I/R) injury in normolipidemic and hyperlipidemic animals

  2018cites this paper
• Glucagon‐like peptide‐1 receptor signalling reduces microvascular thrombosis, nitro‐oxidative stress and platelet activation in endotoxaemic mice

  2017cites this paper
• Impaired mitochondria and intracellular calcium transients in the salivary glands of obese rats.

  2017cites this paper
• Biomarkers of oxidative and nitro‐oxidative stress: conventional and novel approaches

  2017cites this paper
• Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury.

  2017cites this paper
• Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase‐4 inhibitor in prediabetic rats

  2017cites this paper
• The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats

  2017cites this paper
• Effects of Metformin Alone and in Combination with Sitagliptin on Oxidative Stress and Proinflammatory Markers in Patients with Diabetes Mellitus Type-2

  2017cites this paper
• Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes

  2017cites this paper
• Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment

  2017cites this paper
• Vildagliptin and caloric restriction for cardioprotection in pre-diabetic rats.

  2017cites this paper
• New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data

  2017cites this paper
• Trigonelline and vildagliptin antidiabetic effect: improvement of insulin signalling pathway

  2017cites this paper
• DPP-4 Inhibitor and Estrogen Share Similar Efficacy Against Cardiac Ischemic-Reperfusion Injury in Obese-Insulin Resistant and Estrogen-Deprived Female Rats

  2017cites this paper
• Alogliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits

  2017cites this paper
• Vagus Nerve Stimulation Improves Cardiac Function by Preventing Mitochondrial Dysfunction in Obese-Insulin Resistant Rats

  2016cites this paper
• Alleviation of renal mitochondrial dysfunction and apoptosis underlies the protective effect of sitagliptin in gentamicin‐induced nephrotoxicity

  2016cites this paper
• An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes Mellitus

  2016cites this paper
• Estrogen and DPP4 inhibitor, but not metformin, exert cardioprotection via attenuating cardiac mitochondrial dysfunction in obese insulin-resistant and estrogen-deprived female rats

  2016cites this paper
• Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre‐diabetic rats

  2016cites this paper
• Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction.

  2016cites this paper
• Dipeptidyl peptidase‐4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction

  2015cites this paper
• Vasonatrin peptide attenuates myocardial ischemia-reperfusion injury in diabetic rats and underlying mechanisms.

  2015cites this paper
• Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus[S]

  2015cites this paper
• Heart Rate Variability as an Alternative Indicator for Identifying Cardiac Iron Status in Non-Transfusion Dependent Thalassemia Patients

  2015cites this paper
• Comparison between symbolic and spectral analyses of short-term heart rate variability in a subsample of the ELSA-Brasil study

  2015cites this paper
• Inhibition of DPP-4 reduces acute mortality after myocardial infarction with restoration of autophagic response in type 2 diabetic rats

  2015cites this paper
• Effects of PPARγ agonist on heart rate variability and cardiac mitochondrial function in obese-insulin resistant rats.

  2015cites this paper
• Obese-insulin resistance accelerates and aggravates cardiometabolic disorders and cardiac mitochondrial dysfunction in estrogen-deprived female rats

  2015cites this paper
• Possible Protective Mechanisms of Sitagliptin against Isoproternol Induced Myocardial Injury in Rat

  2015cites this paper